Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series

Abstract Background Recent alerts have highlighted an increase in group A streptococcal (GAS) infections since 2022 in Europe and the United States. Streptococcus pyogenes can cause limited skin or mucosal disease, but can also present as severe invasive disease necessitating critical care. We performed a multicenter retrospective study of patients with GAS infections recently admitted to Belgian intensive care units (ICUs) since January 2022. We describe patient characteristics and investigate the molecular epidemiology of the S. pyogenes strains involved. Results Between January 2022 and May... Mehr ...

Verfasser: Marijke Peetermans
Veerle Matheeussen
Cedric Moerman
Fréderic De Rydt
Sabine Thieren
Emily Pollet
Michael Casaer
Benjamin De Backer
Rudi De Paep
Yves Debaveye
Lars Desmet
Stefanie Desmet
Els I. M. Duval
Vincent Fraipont
Dieter Geysels
Greet Hermans
Frederik Lahaye
Xavier Mathy
Philippe Meersseman
Cécile Meex
Jozef Van Herck
Stefanie van Kleef-van Koeveringe
Nathalie Layios
Joost Wauters
Philippe G. Jorens
Dokumenttyp: Artikel
Erscheinungsdatum: 2024
Reihe/Periodikum: Annals of Intensive Care, Vol 14, Iss 1, Pp 1-9 (2024)
Verlag/Hrsg.: SpringerOpen
Schlagwörter: Group A streptococci / Invasive / Streptococcus pyogenes / Necrotizing fasciitis / Toxic shock syndrome / Community-acquired pneumonia / Medical emergencies. Critical care. Intensive care. First aid / RC86-88.9
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28886293
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1186/s13613-024-01249-7

Abstract Background Recent alerts have highlighted an increase in group A streptococcal (GAS) infections since 2022 in Europe and the United States. Streptococcus pyogenes can cause limited skin or mucosal disease, but can also present as severe invasive disease necessitating critical care. We performed a multicenter retrospective study of patients with GAS infections recently admitted to Belgian intensive care units (ICUs) since January 2022. We describe patient characteristics and investigate the molecular epidemiology of the S. pyogenes strains involved. Results Between January 2022 and May 2023, a total of 86 cases (56 adults, 30 children) with GAS disease were admitted to critical care in the university hospitals of Leuven, Antwerp and Liège. We noted a strikingly high incidence of severe community-acquired pneumonia (sCAP) (45% of adults, 77% of children) complicated with empyema in 45% and 83% of adult and pediatric cases, respectively. Two-thirds of patients with S. pyogenes pneumonia had viral co-infection, with influenza (13 adults, 5 children) predominating. Other disease presentations included necrotizing fasciitis (23% of adults), other severe skin/soft tissue infections (16% of adults, 13% of children) and ear/nose/throat infections (13% of adults, 13% of children). Cardiogenic shock was frequent (36% of adults, 20% of children). Fifty-six patients (65%) had toxic shock syndrome. Organ support requirements were high and included invasive mechanical ventilation (77% of adults, 50% of children), renal replacement therapy (29% of adults, 3% of children) and extracorporeal membrane oxygenation (20% of adults, 7% of children). Mortality was 21% in adults and 3% in children. Genomic analysis of S. pyogenes strains from 55 out of 86 patients showed a predominance of emm1 strains (73%), with a replacement of the M1global lineage by the toxigenic M1UK lineage (83% of emm1 strains were M1UK). Conclusions The recent rise of severe GAS infections (2022–23) is associated with introduction of the M1UK lineage in ...